{{Rsnum
|rsid=10825269
|Gene=PCDH15
|Chromosome=10
|position=54195850
|Orientation=plus
|GMAF=0.208
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=PCDH15
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 78.8 | 19.5 | 1.8
| HCB | 79.4 | 20.6 | 0.0
| JPT | 90.3 | 8.8 | 0.9
| YRI | 24.5 | 42.9 | 32.7
| ASW | 35.1 | 47.4 | 17.5
| CHB | 79.4 | 20.6 | 0.0
| CHD | 89.9 | 9.2 | 0.9
| GIH | 67.3 | 26.7 | 5.9
| LWK | 32.7 | 49.1 | 18.2
| MEX | 74.1 | 25.9 | 0.0
| MKK | 32.7 | 51.9 | 15.4
| TSI | 61.4 | 36.6 | 2.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=19816713
|Title=A nonsynonymous SNP within PCDH15 is associated with lipid traits in familial combined hyperlipidemia
|OA=1
}}

{{ClinVar
|rsid=10825269
|Reversed=0
|FwdREF=C
|FwdALT=T
|REF=C
|ALT=T
|RSPOS=55955610
|CHROM=10
|GMAF=0.2079
|dbSNPBuildID=120
|SSR=0
|SAO=1
|VP=0x05036800000015051f100100
|GENEINFO=PCDH15:65217
|GENE_NAME=PCDH15
|GENE_ID=65217
|WGT=0
|VC=SNV
|CLNALLE=1
|CLNHGVS=NC_000010.10:g.55955610C>T
|CLNORIGIN=1
|CLNSIG=2
|Tags=PM;PMC;S3D;SLO;VLD;G5;HD;GNO;KGPhase1;KGPilot123;KGPROD;OTHERKG;PH3;LSD
|CAF=0.792; 0.208
|CLNACC=RCV000039695.1; RCV000086940.1
|CLNDBN=AllHighlyPenetrant; not provided
|CLNDSDB=MedGen
|CLNDSDBID=CN169374
|COMMON=1
|Disease=AllHighlyPenetrant; not provided
}}

{{GET Evidence
|gene=PCDH15
|aa_change=Gly380Ser
|aa_change_short=G380S
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs10825269
|overall_frequency_n=29
|overall_frequency_d=128
|overall_frequency=0.226562
|n_genomes=22
|n_genomes_annotated=0
|n_haplomes=29
|n_articles=0
|n_articles_annotated=0
|gene_in_genetests=Y
|genetests_testable=Y
|genetests_reviewed=Y
|nblosum100=2
|autoscore=3
|n_web_uneval=2
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}